,Approval Date,Company Token,Submission,Active Ingredients,Submission Classification *,Submission Status,Symbol,Name,Market Cap,Country
0,01/04/2021,ani,suppl-9,temozolomide,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
1,01/29/2021,ani,suppl-38,vancomycin hydrochloride,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
2,01/29/2021,ani,suppl-27,vancomycin hydrochloride,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
3,01/29/2021,ani,suppl-28,vancomycin hydrochloride,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
4,02/23/2021,ani,suppl-10,ezetimibe; simvastatin,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
5,09/14/2021,ani,suppl-54,meclizine hydrochloride,manufacturing (cmc),approval,anip,ani pharmaceuticals inc.,698043788.0,united states
6,09/20/2021,ani,suppl-18,fluvoxamine maleate,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
7,09/20/2021,ani,suppl-9,fluoxetine hydrochloride,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
8,08/16/2021,ani,suppl-25,propranolol hydrochloride,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
9,08/27/2021,ani,suppl-6,penicillamine,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
10,04/17/2021,ani,suppl-19,indomethacin,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
11,04/17/2021,ani,suppl-19,indomethacin,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
12,04/26/2021,ani,suppl-3,diflunisal,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
13,04/27/2021,ani,suppl-9,fluconazole,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
14,04/27/2021,ani,suppl-12,fluconazole,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
15,04/27/2021,ani,suppl-13,fluconazole,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
16,04/28/2021,ani,suppl-31,aspirin; oxycodone hydrochloride; oxycodone terephthalate,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
17,04/28/2021,ani,suppl-20,indomethacin,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
18,04/28/2021,ani,suppl-20,indomethacin,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
19,04/28/2021,ani,suppl-24,meclofenamate sodium,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
20,04/28/2021,ani,suppl-25,fenoprofen calcium,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
21,04/28/2021,ani,suppl-17,tolmetin sodium,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
22,04/28/2021,ani,suppl-4,tolmetin sodium,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
23,04/28/2021,ani,suppl-10,tolmetin sodium,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
24,04/28/2021,ani,suppl-16,tolmetin sodium,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
25,04/28/2021,ani,suppl-4,diflunisal,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
26,04/28/2021,ani,suppl-5,etodolac,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
27,04/28/2021,ani,suppl-6,etodolac,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
28,04/28/2021,ani,suppl-12,etodolac,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
29,04/28/2021,ani,suppl-7,hydrocodone bitartrate; ibuprofen,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
30,04/30/2021,ani,suppl-24,sulindac,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
31,03/04/2021,ani,suppl-30,aspirin; oxycodone hydrochloride; oxycodone terephthalate,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
32,03/04/2021,ani,suppl-6,hydrocodone bitartrate; ibuprofen,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
33,10/15/2021,ani,suppl-1,tranexamic acid,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
34,10/29/2021,ani,suppl-8,corticotropin,manufacturing (cmc),approval,anip,ani pharmaceuticals inc.,698043788.0,united states
35,11/03/2021,ani,suppl-13,flecainide acetate,manufacturing (cmc),approval,anip,ani pharmaceuticals inc.,698043788.0,united states
36,11/29/2021,ani,suppl-3,miglustat,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
37,11/30/2021,ani,suppl-2,polyethylene glycol 3350,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
38,12/22/2021,ani,suppl-39,vancomycin hydrochloride,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
39,01/27/2022,ani,suppl-3,nebivolol hydrochloride,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
40,03/04/2022,ani,suppl-6,amoxicillin; clarithromycin; lansoprazole,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
41,03/04/2022,ani,suppl-7,amoxicillin; clarithromycin; lansoprazole,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
42,03/10/2022,ani,suppl-9,amoxicillin; clarithromycin; lansoprazole,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
43,04/08/2022,ani,suppl-3,potassium citrate,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
44,05/24/2022,ani,suppl-14,oxiconazole nitrate,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
45,05/25/2022,ani,suppl-10,fenofibrate,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
46,07/14/2022,ani,suppl-15,misoprostol,manufacturing (cmc),approval,anip,ani pharmaceuticals inc.,698043788.0,united states
47,09/20/2022,ani,suppl-21,fluvoxamine maleate,manufacturing (cmc),approval,anip,ani pharmaceuticals inc.,698043788.0,united states
48,09/22/2022,ani,suppl-32,sulfamethoxazole; trimethoprim,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
49,09/22/2022,ani,suppl-33,sulfamethoxazole; trimethoprim,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
50,09/26/2022,ani,suppl-5,nicardipine hydrochloride,manufacturing (cmc),approval,anip,ani pharmaceuticals inc.,698043788.0,united states
51,10/13/2022,ani,suppl-69,lithium carbonate,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
52,10/18/2022,ani,suppl-14,sodium polystyrene sulfonate,labeling,approval,anip,ani pharmaceuticals inc.,698043788.0,united states
53,01/04/2021,amneal,suppl-5,sevelamer carbonate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
54,01/04/2021,amneal,suppl-3,solifenacin succinate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
55,01/06/2021,amneal,suppl-10,omega-3-acid ethyl esters,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
56,01/14/2021,amneal,suppl-25,buprenorphine hydrochloride; naloxone hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
57,01/14/2021,amneal,suppl-26,buprenorphine hydrochloride; naloxone hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
58,01/15/2021,amneal,suppl-9,mycophenolate mofetil,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
59,01/25/2021,amneal,orig-1,arsenic trioxide,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
60,02/02/2021,amneal,suppl-3,buprenorphine,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
61,02/09/2021,amneal,orig-1,deferasirox,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
62,02/11/2021,amneal,suppl-11,lamotrigine,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
63,02/17/2021,amneal,suppl-13,fosphenytoin sodium,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
64,02/17/2021,amneal,suppl-2,estradiol,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
65,02/17/2021,amneal,suppl-3,estradiol,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
66,02/22/2021,amneal,suppl-17,spironolactone,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
67,02/24/2021,amneal,suppl-6,succinylcholine chloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
68,02/25/2021,amneal,orig-1,ethinyl estradiol; norelgestromin,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
69,09/03/2021,amneal,suppl-5,escitalopram oxalate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
70,09/03/2021,amneal,suppl-6,escitalopram oxalate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
71,09/03/2021,amneal,suppl-10,escitalopram oxalate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
72,09/08/2021,amneal,orig-1,obeticholic acid,,tentative approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
73,09/15/2021,amneal,suppl-6,ezetimibe; simvastatin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
74,09/20/2021,amneal,suppl-13,venlafaxine hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
75,09/20/2021,amneal,suppl-12,escitalopram oxalate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
76,09/21/2021,amneal,orig-1,methylprednisolone,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
77,09/29/2021,amneal,suppl-15,budesonide,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
78,08/02/2021,amneal,suppl-1,deferasirox,manufacturing (cmc),approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
79,08/10/2021,amneal,suppl-20,estradiol; norethindrone acetate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
80,08/10/2021,amneal,suppl-22,estradiol; norethindrone acetate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
81,08/11/2021,amneal,suppl-11,mycophenolate mofetil,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
82,08/11/2021,amneal,suppl-2,mycophenolate mofetil hydrochloride,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
83,08/31/2021,amneal,suppl-12,risperidone,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
84,07/15/2021,amneal,orig-1,dexamethasone; tobramycin,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
85,07/20/2021,amneal,orig-1,ethinyl estradiol; norethindrone acetate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
86,06/03/2021,amneal,suppl-4,fenofibrate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
87,06/07/2021,amneal,suppl-1,oseltamivir phosphate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
88,06/07/2021,amneal,suppl-5,oseltamivir phosphate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
89,06/07/2021,amneal,suppl-7,oseltamivir phosphate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
90,06/14/2021,amneal,orig-1,etravirine,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
91,06/14/2021,amneal,orig-1,clobetasol propionate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
92,06/24/2021,amneal,suppl-2,tranexamic acid,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
93,06/24/2021,amneal,suppl-4,tranexamic acid,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
94,06/30/2021,amneal,orig-1,apremilast,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
95,05/12/2021,amneal,suppl-6,tigecycline,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
96,04/21/2021,amneal,suppl-10,mycophenolate mofetil,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
97,04/21/2021,amneal,suppl-1,mycophenolate mofetil hydrochloride,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
98,04/23/2021,amneal,suppl-1,colchicine,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
99,04/28/2021,amneal,suppl-41,ibuprofen,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
100,04/28/2021,amneal,suppl-42,ibuprofen,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
101,04/28/2021,amneal,suppl-34,ibuprofen,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
102,04/28/2021,amneal,suppl-32,hydrocodone bitartrate; ibuprofen,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
103,04/28/2021,amneal,suppl-32,hydrocodone bitartrate; ibuprofen,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
104,04/28/2021,amneal,suppl-32,ibuprofen,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
105,04/28/2021,amneal,suppl-13,indomethacin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
106,04/28/2021,amneal,suppl-5,etodolac,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
107,04/29/2021,amneal,suppl-7,diclofenac sodium,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
108,03/04/2021,amneal,suppl-28,acetaminophen; hydrocodone bitartrate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
109,03/04/2021,amneal,suppl-29,acetaminophen; hydrocodone bitartrate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
110,03/04/2021,amneal,suppl-23,acetaminophen; oxycodone hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
111,03/04/2021,amneal,suppl-24,acetaminophen; codeine phosphate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
112,03/04/2021,amneal,suppl-30,hydrocodone bitartrate; ibuprofen,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
113,03/04/2021,amneal,suppl-30,hydrocodone bitartrate; ibuprofen,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
114,03/04/2021,amneal,suppl-30,buprenorphine hydrochloride; naloxone hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
115,03/04/2021,amneal,suppl-6,acetaminophen; hydrocodone bitartrate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
116,03/04/2021,amneal,suppl-7,acetaminophen; hydrocodone bitartrate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
117,03/05/2021,amneal,orig-1,mycophenolate mofetil hydrochloride,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
118,03/11/2021,amneal,orig-1,ranolazine,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
119,03/25/2021,amneal,suppl-4,eletriptan hydrobromide,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
120,10/01/2021,amneal,suppl-7,ondansetron hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
121,10/08/2021,amneal,suppl-14,isotretinoin,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
122,10/08/2021,amneal,suppl-3,clobazam,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
123,10/12/2021,amneal,suppl-1,methotrexate sodium,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
124,10/12/2021,amneal,suppl-8,methotrexate sodium,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
125,10/14/2021,amneal,orig-1,dexamethasone,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
126,10/18/2021,amneal,suppl-9,alosetron hydrochloride,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
127,10/25/2021,amneal,orig-1,chlordiazepoxide hydrochloride; clidinium bromide,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
128,10/26/2021,amneal,orig-1,plerixafor,,tentative approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
129,11/01/2021,amneal,suppl-2,acyclovir,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
130,11/02/2021,amneal,orig-1,mycophenolate mofetil,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
131,11/08/2021,amneal,suppl-15,isotretinoin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
132,11/17/2021,amneal,orig-1,difluprednate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
133,11/22/2021,amneal,suppl-3,silodosin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
134,11/22/2021,amneal,orig-1,baclofen,type 3 - new dosage form,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
135,11/30/2021,amneal,orig-1,lubiprostone,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
136,12/02/2021,amneal,orig-1,cinacalcet hydrochloride,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
137,12/03/2021,amneal,suppl-3,clobazam,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
138,12/10/2021,amneal,suppl-14,escitalopram oxalate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
139,12/13/2021,amneal,suppl-38,baclofen,manufacturing (cmc),approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
140,01/03/2022,amneal,orig-1,pirfenidone,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
141,01/04/2022,amneal,orig-1,dihydroergotamine mesylate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
142,01/21/2022,amneal,suppl-5,busulfan,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
143,01/26/2022,amneal,suppl-8,temozolomide,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
144,01/26/2022,amneal,orig-1,atropine sulfate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
145,01/27/2022,amneal,orig-1,carboprost tromethamine,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
146,02/03/2022,amneal,orig-1,azacitidine,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
147,02/04/2022,amneal,suppl-8,prasugrel hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
148,02/07/2022,amneal,suppl-14,ethinyl estradiol; norethindrone acetate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
149,02/10/2022,amneal,suppl-4,amphetamine sulfate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
150,02/25/2022,amneal,suppl-5,amphetamine sulfate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
151,02/28/2022,amneal,orig-1,thiothixene,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
152,03/17/2022,amneal,orig-1,lacosamide,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
153,03/25/2022,amneal,orig-1,pirfenidone,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
154,03/28/2022,amneal,suppl-6,exemestane,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
155,03/31/2022,amneal,suppl-1,ephedrine sulfate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
156,03/31/2022,amneal,suppl-2,ephedrine sulfate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
157,04/05/2022,amneal,suppl-5,fenofibrate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
158,04/13/2022,amneal,orig-1,bevacizumab-maly,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
159,04/15/2022,amneal,orig-1,sucralfate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
160,04/20/2022,amneal,suppl-9,succinylcholine chloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
161,04/27/2022,amneal,orig-1,bexarotene,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
162,04/29/2022,amneal,suppl-15,ethinyl estradiol; norethindrone acetate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
163,04/29/2022,amneal,suppl-8,ethinyl estradiol; norethindrone,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
164,04/29/2022,amneal,suppl-3,ethinyl estradiol; levonorgestrel,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
165,04/29/2022,amneal,suppl-4,ethinyl estradiol; levonorgestrel,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
166,04/29/2022,amneal,suppl-7,ethinyl estradiol; norgestimate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
167,04/29/2022,amneal,suppl-7,ethinyl estradiol; norgestimate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
168,04/29/2022,amneal,suppl-4,ethinyl estradiol; norgestimate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
169,04/29/2022,amneal,suppl-5,bosentan,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
170,04/29/2022,amneal,suppl-3,ethinyl estradiol; norelgestromin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
171,05/03/2022,amneal,suppl-38,buprenorphine hydrochloride; naloxone hydrochloride,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
172,05/05/2022,amneal,suppl-8,clopidogrel bisulfate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
173,05/05/2022,amneal,suppl-12,alosetron hydrochloride,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
174,05/05/2022,amneal,suppl-2,lubiprostone,manufacturing (cmc),approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
175,05/05/2022,amneal,suppl-4,neostigmine methylsulfate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
176,05/16/2022,amneal,orig-1,estradiol; progesterone,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
177,05/27/2022,amneal,suppl-9,aripiprazole,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
178,06/14/2022,amneal,suppl-11,ondansetron hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
179,06/14/2022,amneal,suppl-35,buprenorphine hydrochloride; naloxone hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
180,06/15/2022,amneal,suppl-3,voriconazole,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
181,06/15/2022,amneal,suppl-5,voriconazole,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
182,06/15/2022,amneal,suppl-6,voriconazole,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
183,06/15/2022,amneal,suppl-7,voriconazole,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
184,06/15/2022,amneal,suppl-10,voriconazole,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
185,06/15/2022,amneal,suppl-11,voriconazole,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
186,06/15/2022,amneal,suppl-12,voriconazole,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
187,06/15/2022,amneal,suppl-13,voriconazole,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
188,06/17/2022,amneal,suppl-37,buprenorphine hydrochloride; naloxone hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
189,06/17/2022,amneal,suppl-40,buprenorphine hydrochloride; naloxone hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
190,06/22/2022,amneal,orig-1,vigabatrin,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
191,06/29/2022,amneal,orig-1,enalapril maleate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
192,07/11/2022,amneal,orig-1,spironolactone,,tentative approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
193,07/14/2022,amneal,suppl-9,azithromycin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
194,07/14/2022,amneal,orig-1,atropine sulfate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
195,07/21/2022,amneal,suppl-17,valsartan,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
196,08/04/2022,amneal,orig-1,pemetrexed disodium,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
197,08/05/2022,amneal,orig-1,vasopressin,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
198,08/05/2022,amneal,orig-1,clindamycin phosphate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
199,08/10/2022,amneal,orig-1,vasopressin,,tentative approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
200,08/16/2022,amneal,orig-1,ipratropium bromide,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
201,08/16/2022,amneal,orig-1,ipratropium bromide,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
202,08/18/2022,amneal,orig-1,lisdexamfetamine dimesylate,,tentative approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
203,08/18/2022,amneal,orig-1,diclofenac sodium,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
204,08/23/2022,amneal,suppl-14,warfarin sodium,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
205,08/24/2022,amneal,suppl-16,fosphenytoin sodium,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
206,08/24/2022,amneal,suppl-19,fosphenytoin sodium,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
207,08/24/2022,amneal,suppl-19,isotretinoin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
208,09/02/2022,amneal,suppl-14,abiraterone acetate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
209,09/08/2022,amneal,orig-1,dexamethasone,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
210,09/16/2022,amneal,suppl-26,sulfamethoxazole; trimethoprim,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
211,09/16/2022,amneal,suppl-29,sulfamethoxazole; trimethoprim,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
212,09/21/2022,amneal,suppl-33,tramadol hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
213,09/21/2022,amneal,suppl-35,tramadol hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
214,09/21/2022,amneal,suppl-38,tramadol hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
215,09/21/2022,amneal,suppl-39,tramadol hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
216,09/21/2022,amneal,suppl-40,tramadol hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
217,09/21/2022,amneal,suppl-43,tramadol hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
218,09/21/2022,amneal,suppl-48,tramadol hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
219,09/21/2022,amneal,suppl-49,tramadol hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
220,09/28/2022,amneal,suppl-1,dihydroergotamine mesylate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
221,09/30/2022,amneal,orig-1,saxagliptin,,tentative approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
222,10/06/2022,amneal,suppl-20,isotretinoin,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
223,10/07/2022,amneal,suppl-2,oxaprozin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
224,10/07/2022,amneal,suppl-8,oxaprozin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
225,10/07/2022,amneal,suppl-10,oxaprozin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
226,10/11/2022,amneal,suppl-10,raloxifene hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
227,10/11/2022,amneal,suppl-1,pirfenidone,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
228,10/12/2022,amneal,suppl-1,vigabatrin,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
229,10/12/2022,amneal,suppl-14,vigabatrin,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
230,10/21/2022,amneal,orig-1,glycopyrrolate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
231,10/24/2022,amneal,orig-1,doxycycline hyclate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
232,10/25/2022,amneal,orig-1,prednisolone sodium phosphate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
233,10/28/2022,amneal,suppl-2,mesalamine,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
234,10/28/2022,amneal,suppl-6,mesalamine,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
235,10/28/2022,amneal,orig-1,leuprolide acetate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
236,11/01/2022,amneal,suppl-4,oxcarbazepine,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
237,11/01/2022,amneal,suppl-5,oxcarbazepine,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
238,11/01/2022,amneal,suppl-6,oxcarbazepine,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
239,11/03/2022,amneal,orig-1,clindamycin phosphate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
240,11/08/2022,amneal,suppl-5,vigabatrin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
241,11/08/2022,amneal,suppl-7,vigabatrin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
242,11/08/2022,amneal,suppl-13,vigabatrin,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
243,11/15/2022,amneal,orig-1,mupirocin calcium,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
244,11/16/2022,amneal,suppl-5,neostigmine methylsulfate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
245,11/28/2022,amneal,orig-1,prochlorperazine edisylate,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
246,12/02/2022,amneal,orig-1,amlodipine benzoate,,tentative approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
247,12/09/2022,amneal,suppl-9,hydroxychloroquine sulfate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
248,12/09/2022,amneal,suppl-12,hydroxychloroquine sulfate,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
249,12/13/2022,amneal,orig-1,esmolol hydrochloride,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
250,12/14/2022,amneal,suppl-1,levoleucovorin calcium,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
251,12/14/2022,amneal,suppl-7,levoleucovorin calcium,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
252,12/14/2022,amneal,suppl-1,levoleucovorin calcium,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
253,12/14/2022,amneal,suppl-5,levoleucovorin calcium,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
254,12/16/2022,amneal,suppl-42,buprenorphine hydrochloride; naloxone hydrochloride,rems,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
255,12/16/2022,amneal,suppl-9,ezetimibe,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
256,12/19/2022,amneal,suppl-6,potassium chloride,manufacturing (cmc),approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
257,12/21/2022,amneal,suppl-1,mycophenolate mofetil,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
258,12/21/2022,amneal,suppl-4,mycophenolate mofetil,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
259,12/22/2022,amneal,orig-1,posaconazole,,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
260,12/23/2022,amneal,suppl-5,mycophenolate mofetil hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
261,12/23/2022,amneal,suppl-6,mycophenolate mofetil hydrochloride,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
262,12/23/2022,amneal,suppl-1,chlordiazepoxide hydrochloride; clidinium bromide,labeling,approval,amrx,amneal pharmaceuticals inc. class a common stock,300498745.0,
263,01/06/2021,pacira,suppl-36,bupivacaine,labeling,approval,pcrx,pacira biosciences inc. common stock,1960341189.0,united states
264,03/22/2021,pacira,suppl-35,bupivacaine,efficacy,approval,pcrx,pacira biosciences inc. common stock,1960341189.0,united states
265,01/06/2021,sunshine,orig-1,alogliptin,,tentative approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
266,01/06/2021,sunshine,orig-1,alogliptin,,tentative approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
267,01/07/2021,sunshine,suppl-2,tadalafil,labeling,approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
268,01/07/2021,sunshine,suppl-2,tadalafil,labeling,approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
269,02/11/2021,sunshine,orig-1,duloxetine hydrochloride,,approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
270,02/11/2021,sunshine,orig-1,duloxetine hydrochloride,,approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
271,08/30/2021,sunshine,orig-1,linagliptin; metformin hydrochloride,,approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
272,08/30/2021,sunshine,orig-1,linagliptin; metformin hydrochloride,,approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
273,08/31/2021,sunshine,orig-1,linagliptin,,approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
274,08/31/2021,sunshine,orig-1,linagliptin,,approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
275,07/08/2021,sunshine,orig-1,tenofovir alafenamide,,tentative approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
276,07/08/2021,sunshine,orig-1,tenofovir alafenamide,,tentative approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
277,04/28/2021,sunshine,suppl-3,ibuprofen,labeling,approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
278,04/28/2021,sunshine,suppl-3,ibuprofen,labeling,approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
279,11/22/2021,sunshine,suppl-8,azithromycin,labeling,approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
280,11/22/2021,sunshine,suppl-8,azithromycin,labeling,approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
281,01/05/2022,sunshine,orig-1,oseltamivir phosphate,,approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
282,01/05/2022,sunshine,orig-1,oseltamivir phosphate,,approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
283,06/09/2022,sunshine,orig-1,brivaracetam,,approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
284,06/09/2022,sunshine,orig-1,brivaracetam,,approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
285,09/26/2022,sunshine,orig-1,metoprolol succinate,,approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
286,09/26/2022,sunshine,orig-1,metoprolol succinate,,approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
287,10/11/2022,sunshine,suppl-12,azithromycin,manufacturing (cmc),approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
288,10/11/2022,sunshine,suppl-12,azithromycin,manufacturing (cmc),approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
289,10/11/2022,sunshine,suppl-12,azithromycin,manufacturing (cmc),approval,sbfm,sunshine biopharma inc. common stock,12198500.0,canada
290,10/11/2022,sunshine,suppl-12,azithromycin,manufacturing (cmc),approval,sbfmw,sunshine biopharma inc. warrant,0.0,canada
291,01/06/2021,taro,suppl-2,ivermectin,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
292,01/26/2021,taro,orig-1,imiquimod,,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
293,09/08/2021,taro,suppl-8,escitalopram oxalate,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
294,09/08/2021,taro,suppl-9,escitalopram oxalate,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
295,09/08/2021,taro,suppl-10,escitalopram oxalate,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
296,09/21/2021,taro,suppl-11,escitalopram oxalate,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
297,07/15/2021,taro,suppl-14,prednisolone acetate,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
298,07/21/2021,taro,suppl-14,mupirocin,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
299,07/21/2021,taro,suppl-15,mupirocin,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
300,06/17/2021,taro,orig-1,perampanel,,tentative approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
301,06/28/2021,taro,orig-1,clindamycin phosphate,,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
302,05/07/2021,taro,orig-1,tavaborole,,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
303,04/02/2021,taro,suppl-1,diclofenac sodium,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
304,04/19/2021,taro,orig-1,azelaic acid,,tentative approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
305,04/28/2021,taro,suppl-26,etodolac,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
306,04/28/2021,taro,suppl-17,etodolac,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
307,04/28/2021,taro,suppl-14,etodolac,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
308,04/30/2021,taro,suppl-7,diclofenac sodium,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
309,04/30/2021,taro,suppl-8,ibuprofen,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
310,03/25/2021,taro,orig-1,clobetasol propionate,,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
311,10/04/2021,taro,orig-1,oxymetazoline hydrochloride,,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
312,10/07/2021,taro,suppl-9,desoximetasone,efficacy,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
313,11/12/2021,taro,suppl-3,naftifine hydrochloride,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
314,11/16/2021,taro,orig-1,sildenafil citrate,,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
315,01/14/2022,taro,orig-1,adapalene,,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
316,04/14/2022,taro,orig-1,fluphenazine hydrochloride,,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
317,05/27/2022,taro,suppl-21,enalapril maleate; hydrochlorothiazide,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
318,09/29/2022,taro,orig-1,diclofenac sodium,,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
319,10/18/2022,taro,suppl-8,fluorouracil,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
320,10/31/2022,taro,suppl-4,azelaic acid,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
321,10/31/2022,taro,suppl-5,azelaic acid,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
322,11/07/2022,taro,suppl-11,fluorouracil,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
323,12/14/2022,taro,suppl-1,deferiprone,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
324,12/14/2022,taro,suppl-4,deferiprone,labeling,approval,taro,taro pharmaceutical industries ltd. ordinary shares,1015167906.0,israel
325,01/11/2021,paratek,suppl-12,omadacycline tosylate,labeling,approval,prtk,paratek pharmaceuticals inc. common stock,99068950.0,united states
326,01/11/2021,paratek,suppl-11,omadacycline tosylate,labeling,approval,prtk,paratek pharmaceuticals inc. common stock,99068950.0,united states
327,05/27/2021,paratek,suppl-11,omadacycline tosylate,efficacy,approval,prtk,paratek pharmaceuticals inc. common stock,99068950.0,united states
328,05/27/2021,paratek,suppl-10,omadacycline tosylate,efficacy,approval,prtk,paratek pharmaceuticals inc. common stock,99068950.0,united states
329,01/14/2021,evoke,suppl-1,metoclopramide hydrochloride,labeling,approval,evok,evoke pharma inc. common stock,7354754.0,united states
330,01/14/2021,urogen,suppl-1,mitomycin,labeling,approval,urgn,urogen pharma ltd. ordinary shares,275426122.0,israel
331,01/15/2021,maia,orig-1,baclofen,,approval,maia,maia biotechnology inc. common stock,30681067.0,
332,06/10/2021,maia,orig-1,sodium benzoate; sodium phenylacetate,type 5 - new formulation or new manufacturer,approval,maia,maia biotechnology inc. common stock,30681067.0,
333,07/27/2022,maia,orig-1,bortezomib,type 5 - new formulation or new manufacturer,approval,maia,maia biotechnology inc. common stock,30681067.0,
334,11/22/2022,maia,orig-1,sincalide,type 5 - new formulation or new manufacturer,approval,maia,maia biotechnology inc. common stock,30681067.0,
335,01/22/2021,organon,suppl-7,sugammadex sodium,efficacy,approval,ogn,organon & co. common stock ,5696901283.0,
336,01/22/2021,organon,suppl-9,sugammadex sodium,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
337,02/16/2021,organon,suppl-32,mometasone furoate,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
338,02/22/2021,organon,suppl-74,montelukast sodium,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
339,02/22/2021,organon,suppl-76,montelukast sodium,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
340,02/22/2021,organon,suppl-52,montelukast sodium,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
341,08/25/2021,organon,suppl-49,finasteride,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
342,06/15/2021,organon,suppl-47,finasteride,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
343,06/15/2021,organon,suppl-28,finasteride,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
344,06/25/2021,organon,suppl-8,sugammadex sodium,efficacy,approval,ogn,organon & co. common stock ,5696901283.0,
345,04/13/2021,organon,suppl-48,finasteride,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
346,10/15/2021,organon,suppl-64,losartan potassium,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
347,11/18/2021,organon,suppl-38,mirtazapine,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
348,11/18/2021,organon,suppl-28,mirtazapine,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
349,03/07/2022,organon,suppl-99,simvastatin,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
350,04/29/2022,organon,suppl-40,ethinyl estradiol; etonogestrel,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
351,05/31/2022,organon,suppl-102,simvastatin,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
352,06/28/2022,organon,suppl-56,mometasone furoate,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
353,08/01/2022,organon,suppl-30,finasteride,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
354,09/06/2022,organon,suppl-65,betamethasone acetate; betamethasone sodium phosphate,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
355,11/17/2022,organon,suppl-12,sugammadex sodium,labeling,approval,ogn,organon & co. common stock ,5696901283.0,
356,01/22/2021,aurinia,orig-1,voclosporin,type 1 - new molecular entity,approval,auph,aurinia pharmaceuticals inc ordinary shares,1657048994.0,canada
357,01/27/2021,athenex,orig-1,furosemide,,approval,atnx,athenex inc. common stock,11608700.0,united states
358,03/12/2021,athenex,orig-1,lincomycin hydrochloride,,approval,atnx,athenex inc. common stock,11608700.0,united states
359,01/07/2022,athenex,suppl-13,famotidine,labeling,approval,atnx,athenex inc. common stock,11608700.0,united states
360,01/29/2021,journey,suppl-3,minocycline hydrochloride,labeling,approval,derm,journey medical corporation common stock,27641478.0,united states
361,01/13/2022,journey,suppl-7,minocycline hydrochloride,manufacturing (cmc),approval,derm,journey medical corporation common stock,27641478.0,united states
362,10/28/2022,journey,suppl-5,glycopyrronium tosylate,labeling,approval,derm,journey medical corporation common stock,27641478.0,united states
363,02/05/2021,bausch,suppl-67,chlordiazepoxide hydrochloride; clidinium bromide,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
364,02/05/2021,bausch,suppl-48,lorazepam,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
365,02/05/2021,bausch,suppl-21,diazepam,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
366,02/05/2021,bausch,suppl-21,diazepam,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
367,02/05/2021,bausch,suppl-51,chlordiazepoxide hydrochloride,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
368,02/12/2021,bausch,suppl-25,cyclopentolate hydrochloride,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
369,09/03/2021,bausch,suppl-13,latanoprost,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
370,08/18/2021,bausch,suppl-22,desmopressin acetate,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
371,08/18/2021,bausch,suppl-23,desmopressin acetate,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
372,08/18/2021,bausch,orig-1,brinzolamide,,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
373,07/08/2021,bausch,suppl-43,bupropion hydrochloride,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
374,07/08/2021,bausch,suppl-21,bupropion hydrobromide,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
375,07/19/2021,bausch,suppl-31,phytonadione,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
376,06/16/2021,bausch,suppl-10,selegiline hydrochloride,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
377,06/21/2021,bausch,suppl-38,tobramycin,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
378,06/21/2021,bausch,suppl-39,tobramycin,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
379,04/14/2021,bausch,suppl-17,ketotifen fumarate,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
380,04/14/2021,bausch,suppl-17,ketotifen fumarate,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
381,04/28/2021,bausch,suppl-30,aspirin; caffeine; orphenadrine citrate,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
382,04/28/2021,bausch,suppl-30,aspirin; caffeine; orphenadrine citrate,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
383,03/25/2021,bausch,suppl-22,diazepam,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
384,03/25/2021,bausch,suppl-22,diazepam,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
385,10/14/2021,bausch,suppl-63,fluorouracil,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
386,10/22/2021,bausch,orig-1,triamcinolone acetonide,type 3 - new dosage form,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
387,10/25/2021,bausch,suppl-26,loteprednol etabonate; tobramycin,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
388,11/17/2021,bausch,suppl-80,timolol maleate,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
389,11/29/2021,bausch,suppl-13,brimonidine tartrate,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
390,02/15/2022,bausch,suppl-34,flucytosine,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
391,02/22/2022,bausch,suppl-5,tetracaine hydrochloride,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
392,03/04/2022,bausch,suppl-44,bupropion hydrochloride,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
393,03/04/2022,bausch,suppl-22,bupropion hydrobromide,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
394,03/15/2022,bausch,orig-1,atropine sulfate,type 5 - new formulation or new manufacturer,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
395,03/31/2022,bausch,suppl-10,efinaconazole,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
396,04/28/2022,bausch,suppl-17,nabilone,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
397,05/09/2022,bausch,suppl-45,dihydroergotamine mesylate,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
398,05/09/2022,bausch,suppl-26,dihydroergotamine mesylate,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
399,09/23/2022,bausch,suppl-33,naphazoline hydrochloride; pheniramine maleate,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
400,10/20/2022,bausch,suppl-33,isoproterenol hydrochloride,labeling,approval,bhc,bausch health companies inc. common stock,2121622851.0,canada
401,02/05/2021,united,suppl-25,amitriptyline hydrochloride; chlordiazepoxide,labeling,approval,uthr,united therapeutics corporation common stock,9924296947.0,united states
402,02/05/2021,united,suppl-21,amitriptyline hydrochloride; chlordiazepoxide,labeling,approval,uthr,united therapeutics corporation common stock,9924296947.0,united states
403,02/05/2021,united,suppl-20,oxazepam,labeling,approval,uthr,united therapeutics corporation common stock,9924296947.0,united states
404,07/30/2021,united,suppl-32,treprostinil,manufacturing (cmc),approval,uthr,united therapeutics corporation common stock,9924296947.0,united states
405,03/31/2021,united,suppl-17,treprostinil,efficacy,approval,uthr,united therapeutics corporation common stock,9924296947.0,united states
406,05/20/2022,united,suppl-20,treprostinil,labeling,approval,uthr,united therapeutics corporation common stock,9924296947.0,united states
407,05/23/2022,united,orig-1,treprostinil,type 5 - new formulation or new manufacturer,approval,uthr,united therapeutics corporation common stock,9924296947.0,united states
408,02/05/2021,tg,orig-1,umbralisib tosylate,type 1 - new molecular entity,approval,tgtx,tg therapeutics inc. common stock,5010009837.0,united states
409,02/05/2021,tg,orig-2,umbralisib tosylate,efficacy,approval,tgtx,tg therapeutics inc. common stock,5010009837.0,united states
410,12/28/2022,tg,orig-1,ublituximab-xiiy,,approval,tgtx,tg therapeutics inc. common stock,5010009837.0,united states
411,02/11/2021,jazz,suppl-35,sodium oxybate,rems,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
412,02/11/2021,jazz,suppl-1,calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate,labeling,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
413,02/11/2021,jazz,suppl-2,calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate,rems,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
414,08/12/2021,jazz,suppl-36,sodium oxybate,rems,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
415,08/12/2021,jazz,suppl-6,calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate,efficacy,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
416,07/15/2021,jazz,suppl-2,asparaginase erwinia chrysanthemi (recombinant)-rywn,,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
417,06/23/2021,jazz,suppl-5,calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate,labeling,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
418,06/30/2021,jazz,orig-1,asparaginase erwinia chrysanthemi (recombinant)-rywn,,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
419,12/09/2021,jazz,suppl-38,sodium oxybate,rems,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
420,12/09/2021,jazz,suppl-8,calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate,rems,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
421,02/09/2022,jazz,suppl-39,sodium oxybate,rems,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
422,02/09/2022,jazz,suppl-9,calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate,rems,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
423,04/01/2022,jazz,suppl-4,lurbinectedin,labeling,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
424,08/22/2022,jazz,suppl-40,sodium oxybate,labeling,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
425,08/22/2022,jazz,suppl-10,calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate,labeling,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
426,11/18/2022,jazz,suppl-1,asparaginase erwinia chrysanthemi (recombinant)-rywn,,approval,jazz,jazz pharmaceuticals plc common stock (ireland),8821434885.0,ireland
427,02/11/2021,scilex,suppl-1,colchicine,manufacturing (cmc),approval,sclx,scilex holding company common stock,777454697.0,united states
428,02/11/2021,scilex,suppl-1,colchicine,manufacturing (cmc),approval,sclxw,scilex holding company warrant,0.0,united states
429,04/08/2021,scilex,suppl-5,lidocaine,efficacy,approval,sclx,scilex holding company common stock,777454697.0,united states
430,04/08/2021,scilex,suppl-5,lidocaine,efficacy,approval,sclxw,scilex holding company warrant,0.0,united states
431,04/28/2021,scilex,suppl-2,celecoxib,labeling,approval,sclx,scilex holding company common stock,777454697.0,united states
432,04/28/2021,scilex,suppl-2,celecoxib,labeling,approval,sclxw,scilex holding company warrant,0.0,united states
433,02/12/2021,g1,orig-1,trilaciclib dihydrochloride,type 1 - new molecular entity,approval,gthx,g1 therapeutics inc. common stock,158847265.0,united states
434,02/18/2021,perrigo,suppl-23,famotidine,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
435,08/18/2021,perrigo,suppl-28,famotidine,manufacturing (cmc),approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
436,07/09/2021,perrigo,suppl-31,loperamide hydrochloride; simethicone,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
437,07/09/2021,perrigo,suppl-9,loperamide hydrochloride; simethicone,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
438,10/13/2021,perrigo,suppl-11,polyethylene glycol 3350,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
439,10/13/2021,perrigo,suppl-13,polyethylene glycol 3350,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
440,12/13/2021,perrigo,suppl-12,loperamide hydrochloride,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
441,12/13/2021,perrigo,suppl-16,loperamide hydrochloride,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
442,01/05/2022,perrigo,suppl-13,nicotine polacrilex,manufacturing (cmc),approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
443,01/06/2022,perrigo,suppl-13,nicotine polacrilex,manufacturing (cmc),approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
444,03/01/2022,perrigo,suppl-29,lansoprazole,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
445,03/17/2022,perrigo,orig-1,mometasone furoate,type 8 - partial rx to otc switch,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
446,06/16/2022,perrigo,suppl-14,polyethylene glycol 3350,manufacturing (cmc),approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
447,06/23/2022,perrigo,suppl-30,lansoprazole,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
448,07/15/2022,perrigo,suppl-4,mometasone furoate,manufacturing (cmc),approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
449,07/15/2022,perrigo,suppl-6,mometasone furoate,manufacturing (cmc),approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
450,09/16/2022,perrigo,suppl-5,mometasone furoate,manufacturing (cmc),approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
451,09/19/2022,perrigo,suppl-11,mometasone furoate,labeling,tentative approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
452,09/20/2022,perrigo,suppl-7,mometasone furoate,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
453,09/20/2022,perrigo,suppl-8,mometasone furoate,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
454,09/28/2022,perrigo,suppl-14,diclofenac sodium,manufacturing (cmc),approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
455,10/25/2022,perrigo,suppl-2,atorvastatin calcium,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
456,11/15/2022,perrigo,suppl-32,ibuprofen,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
457,11/15/2022,perrigo,suppl-34,ibuprofen,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
458,11/15/2022,perrigo,suppl-43,ibuprofen,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
459,12/29/2022,perrigo,suppl-31,lansoprazole,labeling,approval,prgo,perrigo company plc ordinary shares,4826103767.0,united states
460,09/02/2021,impel,orig-1,dihydroergotamine mesylate,type 5 - new formulation or new manufacturer,approval,impl,impel pharmaceuticals inc. common stock,60552955.0,united states
461,09/27/2021,cumberland,suppl-20,acetylcysteine,labeling,approval,cpix,cumberland pharmaceuticals inc. common stock,24472182.0,united states
462,04/28/2021,cumberland,suppl-18,ibuprofen,labeling,approval,cpix,cumberland pharmaceuticals inc. common stock,24472182.0,united states
463,11/19/2021,cumberland,suppl-21,ibuprofen,efficacy,approval,cpix,cumberland pharmaceuticals inc. common stock,24472182.0,united states
464,03/04/2022,cumberland,suppl-10,amoxicillin; clarithromycin; omeprazole,labeling,approval,cpix,cumberland pharmaceuticals inc. common stock,24472182.0,united states
465,12/06/2022,cumberland,suppl-20,ibuprofen,labeling,approval,cpix,cumberland pharmaceuticals inc. common stock,24472182.0,united states
466,09/29/2021,mirum,orig-1,maralixibat chloride,type 1 - new molecular entity,approval,mirm,mirum pharmaceuticals inc. common stock,999628497.0,united states
467,04/01/2022,mirum,suppl-1,maralixibat chloride,labeling,approval,mirm,mirum pharmaceuticals inc. common stock,999628497.0,united states
468,08/03/2021,emergent,suppl-1,brincidofovir,labeling,approval,ebs,emergent biosolutions inc. common stock,450057801.0,united states
469,08/03/2021,emergent,suppl-1,brincidofovir,labeling,approval,ebs,emergent biosolutions inc. common stock,450057801.0,united states
470,06/04/2021,emergent,orig-1,brincidofovir,type 2 - new active ingredient,approval,ebs,emergent biosolutions inc. common stock,450057801.0,united states
471,06/04/2021,emergent,orig-1,brincidofovir,type 2 - new active ingredient,approval,ebs,emergent biosolutions inc. common stock,450057801.0,united states
472,08/05/2021,aquestive,suppl-7,ondansetron,labeling,approval,aqst,aquestive therapeutics inc. common stock,113417229.0,united states
473,08/30/2022,aquestive,orig-1,diazepam,type 3 - new dosage form,tentative approval,aqst,aquestive therapeutics inc. common stock,113417229.0,united states
474,08/20/2021,xeris,suppl-7,glucagon,labeling,approval,xers,xeris biopharma holdings inc. common stock,330865531.0,united states
475,08/20/2021,xeris,suppl-7,glucagon,labeling,approval,xers,xeris biopharma holdings inc. common stock,330865531.0,united states
476,08/20/2021,xeris,suppl-7,glucagon,labeling,approval,xers,xeris biopharma holdings inc. common stock,330865531.0,united states
477,07/15/2021,xeris,suppl-8,glucagon,labeling,approval,xers,xeris biopharma holdings inc. common stock,330865531.0,united states
478,07/15/2021,xeris,suppl-8,glucagon,labeling,approval,xers,xeris biopharma holdings inc. common stock,330865531.0,united states
479,07/15/2021,xeris,suppl-8,glucagon,labeling,approval,xers,xeris biopharma holdings inc. common stock,330865531.0,united states
480,08/23/2021,cara,orig-1,difelikefalin acetate,type 1 - new molecular entity,approval,cara,cara therapeutics inc. common stock,236677534.0,united states
481,08/25/2021,ascendis,orig-1,lonapegsomatropin-tcgd,,approval,asnd,ascendis pharma a/s american depositary shares,5413465382.0,denmark
482,10/20/2022,ascendis,suppl-1,lonapegsomatropin-tcgd,,approval,asnd,ascendis pharma a/s american depositary shares,5413465382.0,denmark
483,07/15/2021,baudax,suppl-2,meloxicam,labeling,approval,bxrx,baudax bio inc. common stock,1951946.0,united states
484,04/28/2021,baudax,suppl-1,meloxicam,labeling,approval,bxrx,baudax bio inc. common stock,1951946.0,united states
485,06/01/2021,scynexis,orig-1,ibrexafungerp citrate,type 1 - new molecular entity,approval,scyx,scynexis inc. common stock,99972393.0,united states
486,06/15/2022,scynexis,suppl-1,ibrexafungerp citrate,labeling,approval,scyx,scynexis inc. common stock,99972393.0,united states
487,11/30/2022,scynexis,suppl-2,ibrexafungerp citrate,efficacy,approval,scyx,scynexis inc. common stock,99972393.0,united states
488,06/02/2021,morphosys,suppl-1,tafasitamab-cxix,,approval,mor,morphosys ag american depositary shares,772150764.0,germany
489,06/16/2021,blueprint,suppl-6,avapritinib,efficacy,approval,bpmc,blueprint medicines corporation common stock,3361477189.0,united states
490,06/16/2021,blueprint,suppl-7,avapritinib,efficacy,approval,bpmc,blueprint medicines corporation common stock,3361477189.0,united states
491,06/17/2021,deciphera,suppl-1,ripretinib,labeling,approval,dcph,deciphera pharmaceuticals inc. common stock,1023009915.0,united states
492,09/15/2022,deciphera,suppl-3,ripretinib,labeling,approval,dcph,deciphera pharmaceuticals inc. common stock,1023009915.0,united states
493,12/29/2022,deciphera,suppl-4,ripretinib,labeling,approval,dcph,deciphera pharmaceuticals inc. common stock,1023009915.0,united states
494,06/25/2021,aytu,suppl-32,methylphenidate hydrochloride,labeling,approval,aytu,aytu biopharma inc.  common stock,5819232.0,united states
495,03/25/2021,aytu,suppl-6,carbinoxamine maleate,labeling,approval,aytu,aytu biopharma inc.  common stock,5819232.0,united states
496,04/22/2022,aytu,suppl-25,methylphenidate hydrochloride,labeling,approval,aytu,aytu biopharma inc.  common stock,5819232.0,united states
497,06/28/2021,puma,suppl-9,neratinib maleate,efficacy,approval,pbyi,puma biotechnology inc common stock,148319191.0,united states
498,06/29/2021,adamis,suppl-12,epinephrine,labeling,approval,admp,adamis pharmaceuticals corporation common stock,12902453.0,united states
499,10/15/2021,adamis,orig-1,naloxone hydrochloride,type 5 - new formulation or new manufacturer,approval,admp,adamis pharmaceuticals corporation common stock,12902453.0,united states
500,06/29/2021,ptc,suppl-5,deflazacort,labeling,approval,ptct,ptc therapeutics inc. common stock,4124790247.0,united states
501,06/29/2021,ptc,suppl-5,deflazacort,labeling,approval,ptct,ptc therapeutics inc. common stock,4124790247.0,united states
502,05/05/2021,rvl,suppl-4,oxymetazoline hydrochloride,labeling,approval,rvlp,rvl pharmaceuticals plc ordinary shares,78655248.0,united states
503,05/06/2021,alkermes,suppl-55,naltrexone,rems,approval,alks,alkermes plc ordinary shares,4830574379.0,ireland
504,05/28/2021,alkermes,orig-1,olanzapine; samidorphan l-malate,type 1 - new molecular entity and type 4 - new combination,approval,alks,alkermes plc ordinary shares,4830574379.0,ireland
505,05/28/2021,alkermes,orig-2,olanzapine; samidorphan l-malate,type 1 - new molecular entity and type 4 - new combination,approval,alks,alkermes plc ordinary shares,4830574379.0,ireland
506,03/04/2021,alkermes,suppl-52,naltrexone,labeling,approval,alks,alkermes plc ordinary shares,4830574379.0,ireland
507,03/30/2021,alkermes,suppl-21,aripiprazole lauroxil,labeling,approval,alks,alkermes plc ordinary shares,4830574379.0,ireland
508,03/30/2021,alkermes,suppl-9,aripiprazole lauroxil,labeling,approval,alks,alkermes plc ordinary shares,4830574379.0,ireland
509,09/30/2022,alkermes,suppl-57,naltrexone,labeling,approval,alks,alkermes plc ordinary shares,4830574379.0,ireland
510,05/19/2021,ardelyx,suppl-3,tenapanor hydrochloride,labeling,approval,ardx,ardelyx inc. common stock,956061034.0,united states
511,03/05/2021,ardelyx,suppl-2,tenapanor hydrochloride,labeling,approval,ardx,ardelyx inc. common stock,956061034.0,united states
512,04/05/2022,ardelyx,suppl-4,tenapanor hydrochloride,labeling,approval,ardx,ardelyx inc. common stock,956061034.0,united states
513,05/21/2021,blue,suppl-34,fluciclovine f-18,labeling,approval,bwv,blue water biotech inc. common stock,16309058.0,united states
514,05/25/2021,assertio,suppl-13,diclofenac potassium,efficacy,approval,asrt,assertio holdings inc. common stock,344005331.0,united states
515,05/25/2021,assertio,suppl-14,diclofenac potassium,labeling,approval,asrt,assertio holdings inc. common stock,344005331.0,united states
516,04/28/2021,assertio,suppl-13,diclofenac potassium,labeling,approval,asrt,assertio holdings inc. common stock,344005331.0,united states
517,04/28/2021,assertio,suppl-14,diclofenac potassium,labeling,approval,asrt,assertio holdings inc. common stock,344005331.0,united states
518,05/25/2021,biofrontera,suppl-11,aminolevulinic acid hydrochloride,labeling,approval,bfri,biofrontera inc. common stock,15752411.0,united states
519,05/25/2021,biofrontera,suppl-11,aminolevulinic acid hydrochloride,labeling,approval,bfriw,biofrontera inc. warrants,0.0,united states
520,05/26/2021,intercept,suppl-7,obeticholic acid,labeling,approval,icpt,intercept pharmaceuticals inc. common stock,677972852.0,united states
521,02/24/2022,intercept,suppl-8,obeticholic acid,labeling,approval,icpt,intercept pharmaceuticals inc. common stock,677972852.0,united states
522,04/02/2021,supernus,orig-1,viloxazine hydrochloride,type 1 - new molecular entity,approval,supn,supernus pharmaceuticals inc. common stock,1996176146.0,united states
523,02/03/2022,supernus,suppl-29,topiramate,labeling,approval,supn,supernus pharmaceuticals inc. common stock,1996176146.0,united states
524,04/29/2022,supernus,suppl-3,viloxazine hydrochloride,efficacy,approval,supn,supernus pharmaceuticals inc. common stock,1996176146.0,united states
525,10/07/2022,supernus,suppl-30,topiramate,labeling,approval,supn,supernus pharmaceuticals inc. common stock,1996176146.0,united states
526,04/22/2021,theratechnologies,suppl-11,ibalizumab-uiyk,,approval,thtx,theratechnologies inc. common shares,93921471.0,canada
527,10/03/2022,theratechnologies,suppl-13,ibalizumab-uiyk,,approval,thtx,theratechnologies inc. common shares,93921471.0,canada
528,04/23/2021,adc,orig-1,loncastuximab tesirine-lpyl,,approval,adct,adc therapeutics sa common shares,159672203.0,
529,10/12/2022,adc,suppl-4,loncastuximab tesirine-lpyl,,approval,adct,adc therapeutics sa common shares,159672203.0,
530,10/12/2022,adc,suppl-5,loncastuximab tesirine-lpyl,,approval,adct,adc therapeutics sa common shares,159672203.0,
531,04/28/2021,purple,suppl-9,amlodipine besylate; celecoxib,labeling,approval,ppbt,purple biotech ltd. american depositary shares,41623353.0,israel
532,04/29/2021,amphastar,suppl-5,ketorolac tromethamine,labeling,approval,amph,amphastar pharmaceuticals inc. common stock,1761460619.0,united states
533,12/14/2021,amphastar,suppl-32,cosyntropin,labeling,approval,amph,amphastar pharmaceuticals inc. common stock,1761460619.0,united states
534,04/07/2022,amphastar,orig-1,ganirelix acetate,,approval,amph,amphastar pharmaceuticals inc. common stock,1761460619.0,united states
535,05/19/2022,amphastar,suppl-1,neostigmine methylsulfate,labeling,approval,amph,amphastar pharmaceuticals inc. common stock,1761460619.0,united states
536,07/18/2022,amphastar,orig-1,vasopressin,,approval,amph,amphastar pharmaceuticals inc. common stock,1761460619.0,united states
537,11/15/2022,amphastar,suppl-16,enoxaparin sodium,labeling,approval,amph,amphastar pharmaceuticals inc. common stock,1761460619.0,united states
538,11/15/2022,amphastar,suppl-2,enoxaparin sodium,labeling,approval,amph,amphastar pharmaceuticals inc. common stock,1761460619.0,united states
539,04/29/2021,optinose,suppl-10,fluticasone propionate,manufacturing (cmc),approval,optn,optinose inc. common stock,226974448.0,united states
540,04/29/2021,optinose,suppl-11,fluticasone propionate,labeling,approval,optn,optinose inc. common stock,226974448.0,united states
541,03/01/2021,catalyst,suppl-7,amifampridine phosphate,labeling,approval,cbio,catalyst biosciences inc. common stock,6572154.0,united states
542,03/01/2021,catalyst,suppl-7,amifampridine phosphate,labeling,approval,cprx,catalyst pharmaceuticals inc. common stock,1828102543.0,united states
543,09/29/2022,catalyst,suppl-8,amifampridine phosphate,efficacy,approval,cbio,catalyst biosciences inc. common stock,6572154.0,united states
544,09/29/2022,catalyst,suppl-8,amifampridine phosphate,efficacy,approval,cprx,catalyst pharmaceuticals inc. common stock,1828102543.0,united states
545,03/04/2021,collegium,suppl-23,tapentadol hydrochloride,labeling,approval,coll,collegium pharmaceutical inc. common stock,791559548.0,united states
546,03/04/2021,collegium,suppl-23,tapentadol hydrochloride,labeling,approval,coll,collegium pharmaceutical inc. common stock,791559548.0,united states
547,03/04/2021,collegium,suppl-9,tapentadol hydrochloride,labeling,approval,coll,collegium pharmaceutical inc. common stock,791559548.0,united states
548,03/04/2021,collegium,suppl-15,oxycodone,labeling,approval,coll,collegium pharmaceutical inc. common stock,791559548.0,united states
549,03/04/2021,trevena,suppl-1,oliceridine,labeling,approval,trvn,trevena inc. common stock,5744046.0,united states
550,03/16/2021,nabriva,suppl-2,lefamulin acetate,labeling,approval,nbrv,nabriva therapeutics plc ordinary shares ireland,5506504.0,ireland
551,03/16/2021,nabriva,suppl-2,lefamulin acetate,labeling,approval,nbrv,nabriva therapeutics plc ordinary shares ireland,5506504.0,ireland
552,03/18/2021,kiniksa,suppl-49,rilonacept,,approval,knsa,kiniksa pharmaceuticals ltd. class a common stock,971661003.0,united states
553,10/01/2021,redhill,suppl-4,amoxicillin; omeprazole magnesium; rifabutin,labeling,approval,rdhl,redhill biopharma ltd. american depositary shares,3447076850.0,israel
554,03/04/2022,redhill,suppl-7,amoxicillin; omeprazole magnesium; rifabutin,labeling,approval,rdhl,redhill biopharma ltd. american depositary shares,3447076850.0,israel
555,10/07/2021,ocular,suppl-7,dexamethasone,efficacy,approval,ocul,ocular therapeutix inc. common stock,480556631.0,united states
556,10/14/2021,eagle,suppl-10,bendamustine hydrochloride,labeling,approval,egrx,eagle pharmaceuticals inc. common stock,374209350.0,united states
557,10/14/2021,eagle,suppl-24,bendamustine hydrochloride,labeling,approval,egrx,eagle pharmaceuticals inc. common stock,374209350.0,united states
558,12/15/2021,eagle,orig-1,vasopressin,,approval,egrx,eagle pharmaceuticals inc. common stock,374209350.0,united states
559,06/02/2022,eagle,suppl-12,bendamustine hydrochloride,labeling,approval,egrx,eagle pharmaceuticals inc. common stock,374209350.0,united states
560,12/14/2022,eagle,suppl-5,pemetrexed,efficacy,approval,egrx,eagle pharmaceuticals inc. common stock,374209350.0,united states
561,10/20/2021,axsome,suppl-4,solriamfetol hydrochloride,labeling,approval,axsm,axsome therapeutics inc. common stock,3199991836.0,united states
562,08/18/2022,axsome,orig-1,bupropion hydrochloride; dextromethorphan hydrobromide,type 3 - new dosage form and type 4 - new combination,approval,axsm,axsome therapeutics inc. common stock,3199991836.0,united states
563,12/01/2022,axsome,suppl-7,solriamfetol hydrochloride,labeling,approval,axsm,axsome therapeutics inc. common stock,3199991836.0,united states
564,11/22/2021,aadi,orig-1,sirolimus,type 5 - new formulation or new manufacturer,approval,aadi,aadi bioscience inc. common stock,194029701.0,united states
565,11/23/2021,siga,suppl-6,tecovirimat,efficacy,approval,siga,siga technologies inc. common stock,423820862.0,united states
566,05/18/2022,siga,suppl-7,tecovirimat,efficacy,approval,siga,siga technologies inc. common stock,423820862.0,united states
567,05/18/2022,siga,orig-1,tecovirimat,type 3 - new dosage form,approval,siga,siga technologies inc. common stock,423820862.0,united states
568,12/07/2021,dare,orig-1,clindamycin phosphate,type 5 - new formulation or new manufacturer,approval,dare,dare bioscience inc. common stock,86170378.0,united states
569,12/09/2021,veru,orig-1,finasteride; tadalafil,type 4 - new combination,approval,veru,veru inc. common stock,117059651.0,united states
570,12/10/2021,amicus,suppl-5,migalastat hydrochloride,labeling,approval,fold,amicus therapeutics inc. common stock,3430743346.0,united states
571,12/15/2021,calliditas,orig-1,budesonide,type 5 - new formulation or new manufacturer,approval,calt,calliditas therapeutics ab american depositary shares,762988539.0,sweden
572,12/17/2021,intra-cellular,suppl-5,lumateperone tosylate,efficacy,approval,itci,intra-cellular therapies inc. common stock,6073147391.0,united states
573,12/17/2021,intra-cellular,suppl-6,lumateperone tosylate,efficacy,approval,itci,intra-cellular therapies inc. common stock,6073147391.0,united states
574,04/26/2022,intra-cellular,suppl-9,lumateperone tosylate,manufacturing (cmc),approval,itci,intra-cellular therapies inc. common stock,6073147391.0,united states
575,01/28/2022,eton,orig-1,betaine,,approval,eton,eton pharmaceuticals inc. common stock,91540314.0,united states
576,02/03/2022,eton,suppl-1,hydrocortisone,labeling,approval,eton,eton pharmaceuticals inc. common stock,91540314.0,united states
577,12/23/2022,eton,suppl-2,hydrocortisone,labeling,approval,eton,eton pharmaceuticals inc. common stock,91540314.0,united states
578,02/17/2022,agios,orig-1,mitapivat sulfate,type 1 - new molecular entity,approval,agio,agios pharmaceuticals inc. common stock,1434651537.0,united states
579,02/23/2022,sage,orig-1,apomorphine hydrochloride,,approval,sage,sage therapeutics inc. common stock,2924968440.0,united states
580,06/16/2022,sage,suppl-7,brexanolone,efficacy,approval,sage,sage therapeutics inc. common stock,2924968440.0,united states
581,02/28/2022,cti,orig-1,pacritinib citrate,type 1 - new molecular entity,approval,ctic,cti biopharma corp. (de) common stock,643359153.0,united states
582,03/18/2022,marinus,orig-1,ganaxolone,type 1 - new molecular entity,approval,mrns,marinus pharmaceuticals inc. common stock,445992751.0,united states
583,11/09/2022,marinus,suppl-1,ganaxolone,labeling,approval,mrns,marinus pharmaceuticals inc. common stock,445992751.0,united states
584,11/09/2022,marinus,suppl-2,ganaxolone,labeling,approval,mrns,marinus pharmaceuticals inc. common stock,445992751.0,united states
585,04/05/2022,bioxcel,orig-1,dexmedetomidine hydrochloride,type 3 - new dosage form,approval,btai,bioxcel therapeutics inc. common stock,675632093.0,united states
586,10/24/2022,bioxcel,suppl-1,dexmedetomidine hydrochloride,labeling,approval,btai,bioxcel therapeutics inc. common stock,675632093.0,united states
587,04/29/2022,agile,suppl-4,ethinyl estradiol; levonorgestrel,labeling,approval,agrx,agile therapeutics inc. common stock,5536680.0,united states
588,05/03/2022,phathom,orig-1,amoxicillin; clarithromycin; vonoprazan fumarate,type 1 - new molecular entity and type 4 - new combination,approval,phat,phathom pharmaceuticals inc. common stock,536970748.0,united states
589,05/03/2022,phathom,orig-1,amoxicillin; vonoprazan fumarate,type 5 - new formulation or new manufacturer,approval,phat,phathom pharmaceuticals inc. common stock,536970748.0,united states
590,06/16/2022,rhythm,suppl-1,setmelanotide acetate,efficacy,approval,rytm,rhythm pharmaceuticals inc. common stock,958182838.0,united states
591,07/29/2022,arcutis,orig-1,roflumilast,type 3 - new dosage form,approval,arqt,arcutis biotherapeutics inc. common stock,903232978.0,united states
592,09/07/2022,revance,orig-1,daxibotulinumtoxina-lanm,,approval,rvnc,revance therapeutics inc. common stock,2886957669.0,united states
593,09/09/2022,spectrum,orig-1,eflapegrastim-xnst,,approval,sppi,spectrum pharmaceuticals inc.common stock,222733689.0,united states
594,09/27/2022,harrow,orig-1,chloroprocaine hydrochloride,type 3 - new dosage form,approval,hrow,harrow health inc. common stock,809428900.0,united states
595,09/27/2022,harrow,orig-1,chloroprocaine hydrochloride,type 3 - new dosage form,approval,hrowl,harrow health inc. 8.625% senior notes due 2026,0.0,united states
596,09/27/2022,harrow,orig-1,chloroprocaine hydrochloride,type 3 - new dosage form,approval,hrowm,harrow health inc. 11.875% senior notes due 2027,0.0,united states
597,09/29/2022,amylyx,orig-1,sodium phenylbutyrate; taurursodiol,type 1 - new molecular entity,approval,amlx,amylyx pharmaceuticals inc. common stock,1944849427.0,united states
598,10/07/2022,scpharmaceuticals,orig-1,furosemide,type 3 - new dosage form,approval,scph,scpharmaceuticals inc. common stock,406336669.0,united states
599,11/14/2022,immunogen,orig-1,mirvetuximab soravtansine-gynx,,approval,imgn,immunogen inc. common stock,2991720239.0,united states
600,12/01/2022,rigel,orig-1,olutasidenib,type 1 - new molecular entity,approval,rigl,rigel pharmaceuticals inc. common stock,202306156.0,united states
601,12/12/2022,mirati,orig-1,adagrasib,type 1 - new molecular entity,approval,mrtx,mirati therapeutics inc. common stock,2667556032.0,united states
602,12/22/2022,harmony,suppl-3,pitolisant hydrochloride,labeling,approval,hrmy,harmony biosciences holdings inc. common stock,2149449548.0,united states
603,12/22/2022,acer,orig-1,sodium phenylbutyrate,type 5 - new formulation or new manufacturer,approval,acer,acer therapeutics inc. common stock (de),17858920.0,united states
